CervoMed Inc. Common Stock

$2.495
USD
Last updated on --.
24h volume77.81K
24h highest2.6100 USD
24h lowest2.3760 USD
24h Price movement+2.25%

CRVO recent prices

24 Hours
+2.25%+$0.055
30 days
-33.33%-$1.240
60 days
-38.15%-$1.530
90 days
-47.29%-$2.010

Key data

Previous close2.4400 USD
Market cap27.22M USD
Volume77.81K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.2400 USD
Net income (FY)-30.04M USD
Revenue (FY)2.09M USD
Last report dateMay 15, 2026

About CervoMed Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersBOSTON
Employees (FY)15.00
Revenue per employee (FY)139.27K USD
Net income per employee (FY)-2.00M USD
Listed onNasdaq
Official website

CRVO conversion tables

CRVOCRVO
USDUSD
0.5 CRVO1.247 USD
1 CRVO2.495 USD
5 CRVO12.47 USD
10 CRVO24.95 USD
USDUSD
CRVOCRVO
0.5 USD0.2004 CRVO
1 USD0.4008 CRVO
5 USD2.004 CRVO
10 USD4.008 CRVO

FAQ

CRVO is trading at $2.495, +2.25% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CRVO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CRVO is currently trading at $2.495, +2.25% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CRVO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CRVO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CRVO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CRVO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
CervoMed Inc. Common Stock's market cap is currently 27.22M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume77.81K
24h highest2.6100 USD
24h lowest2.3760 USD
24h Price movement+2.25%
CRVOCRVO
USDUSD
Start trade with CRVO Perpetual